Mucosal Leishmaniasis due to Leishmania (Viannia) panamensis in colombia: Clinical characteristics

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 1, 1998, Pages 49-52

  Osorio, Lyda Elena ^a   Castillo, Carmen Manuela ^a   Ochoa, Maria Teresa ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; COLOMBIA; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HUMAN; LEISHMANIA; LEISHMANIA BRAZILIENSIS; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; PARASITE ISOLATION; PHYSICAL EXAMINATION; SKIN LEISHMANIASIS;

EID: 0031778351     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.49     Document Type: Article

References (23)

1. Marsden P, 1986. Mucosal leishmaniasis ("Espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 80: 859-876.
2. Saravia N, Holguín A, McMahon-Pratt D, D'Alessandro A, 1985. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 34: 714-720.
3. Saenz RE, De Rodriguez CG, Johnson CM, Berman JD, 1991. Efficacy and toxicity of Pentostam against Panamian mucosal leishmaniasis. Am J Trop Med Hyg 44: 394-398.
4. Naiff RD, Talhari S, Barrett V, 1988. Isolation of Leishmania guyanensis from lesions of the nasal mucosa. Mem Inst Oswaldo Cruz 83: 529-530.
5. Santrich C, Segura Y, Arias A L, Saravia N, 1990. Mucosal disease caused by Leishmania braziliensis guyanensis. Am J Trop Med Hyg 42: 51-55.
6. Velasco O, Savarino SJ, Waiton BC, Gam AA, Neva FA, 1989. Diffuse cutaneous leishmaniasis in Mexico. Am J Trop Med Hyg 41: 280-288.
7. Grimaldi G, Tesh RB, McMahon-Pratt D, 1989. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 41: 687-725.
8. Grimaldi G, Tesh R, 1993. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 6: 230-250.
9. Saravia N, Valderrama L, Labrada M, Holguin A, Navas C, Palma G, Weigle K, 1989. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 159: 725-735.
10. Escobar M, Martinez F, Smith S, Palma G, 1992. American cutaneous and mucocutaneous leishmaniasis (tegumentary): a diagnostic challenge. Trop Doct 22 (suppl 1): 69-78.
11. Rodríguez G, Sarmiento L, Hernández CA, 1994. Leishmaniasis mucosa y otras lesiones destructivas centrofaciales. Biomédica 14: 215-229.
12. McMahon Pratt D, David JR, 1981. Monoclonal antibodies that distinguish between New World species of Leishmania. Nature 291: 581-582.
13. Franke E, Wignall S, Cruz M, Rosales E, Tovar AA, Lucas CM, Llanos-Cuentas A, Herman JD, 1990. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 113: 934-940.
14. Sáenz RE, Paz HM, de-Rodríguez GC, Vásquez AM, Mata RE, Johnson CM, 1989. Mucocutaneous leishmaniasis in Panama: etiologic agent, epidemiological and clinical aspects. Rev Med Panama 14: 6-15.
15. Llanos-Cuentas EA, Cuba CC, Barreto A, Marsden P, 1984. Clinical characteristics of human Leishmania braziliensis infections. Trans R Soc Trop Med Hyg 78: 845-846.
16. Marsden P, Llanos-Cuentas E, Lago E, Cuba C, Barreto A, Costa JML, Jones TC, 1984. Human mucocutaneous leishmaniasis in Tres Braços, Bahia-Brazil, an area of Leishmania braziliensis transmission. III. Mucosal disease presentation and initial evolution. Rev Soc Bras Med Trop 17: 179-186.
17. Weigle K, Santrich C, Martínez F, Valderrama L, Saravia N, 1993. Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence and incidence of infection and clinical manifestations. J Infect Dis 168: 699-708.
18. Jones TC, Johnson WD, Barreto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF, Wiese K, Golightly L, Fikrig E, Costa JML, Cuba CC, Marsden PD, 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 156: 73-83.
19. Saravia N, Weigle K, Pacheco R, Conclaves A, Segura I, Giannin SH, Labrada LA, 1990. Recurrent lesion in human L. braziliensis infection: reactivation or reinfection. Lancet 336: 398-402.
20. Weigle K, Saravia N, Dávalos M, Moreno LH, D'Alessandro A, 1986. Leishmania braziliensis from the Pacific Coast region of Colombia: foci of transmission clinical spectrum and isoenzyme. Am J Trop Med Hyg 35: 712-731.
21. Guevara P, Rojas E, Gonzalez N, Scorza J, Anez N, Valera M, Ramirez J, 1994. Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. Clin Diagn Lab Immunol 1: 385-389.
22. Waiton BC, Valvente LC, 1979. Racial differences in Espundia. Ann Trop Med Parasitol 73: 23-29.
23. Llanos-Cuentas EA, Marsden P, Cuba CC, Barreto A, Campos M, 1984. Possible risk factors in development of mucosal lesions in leishmaniasis. Lancet ii: 295.